Skip to main content
. 2019 Nov 29;10(4):389–395. doi: 10.1016/j.jtcme.2019.11.003

Table 2.

Effects of different treatments on intestinal disaccharidases, amylase and lipase activities in rats.

Parameters Treatments
NC DC PC HCO LCO
Maltase (μmole glucose/min/g protein) 175.7 ± 14.9B 333.3 ± 41.7A 340.3 ± 36.4A 166.1 ± 19.1B 259.6 ± 36.6AB
Sucrase (μmole glucose/min/g protein) 62.5 ± 3.7AB 77.1 ± 9.4A 70.1 ± 10.7A 31.7 ± 5.4B 57.0 ± 8.2AB
Isomaltase (μmole glucose/min/g protein) 31.3 ± 1.8A 35.8 ± 6.7A 31.0 ± 4.3A 19.6 ± 2.4A 23.4 ± 3.0A
Lactase (μmole glucose/min/g protein) 10.7 ± 0.9AB 14.1 ± 2.0A 11.5 ± 1.9AB 7.4 ± 0.9B 6.7 ± 0.7B
Amylase (U/mg protein) 180.0 ± 42.2B 834.3 ± 174.7A 860.1 ± 191.6A 275.7 ± 68.0B 286.2 ± 70.1B
Lipase (U/mg protein) 207.8 ± 30.6C 580.3 ± 52.0AB 659.3 ± 115.1A 284.7 ± 38.2C 308.2 ± 73.3BC

Results are mean ± SE (n = 6–7). Different letters (A-C) are significantly different (p < 0.05, one-way ANOVA) according to the Tukey’s test. NC: normal control, DC: diabetic control, PC: 30 mg/kg of pioglitazone, HCO: high-dosage C. obtusa var. formosana leaf extracts, LCO: low-dosage C. obtusa var. formosana leaf extracts.